|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
in00000139432 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
180507s2018 nyua o 001 0 eng d |
005 |
20240129204701.5 |
035 |
|
|
|a (OCoLC)spr1034691253
|
037 |
|
|
|a spr978-1-4939-7445-0
|
040 |
|
|
|a GW5XE
|b eng
|e rda
|e pn
|c GW5XE
|d YDX
|d UAB
|d OCLCF
|d OCLCQ
|d STF
|d COO
|d U3W
|d LVT
|d UKMGB
|d CAUOI
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
066 |
|
|
|c (S
|
015 |
|
|
|a GBB8L6889
|2 bnb
|
016 |
7 |
|
|a 019127359
|2 Uk
|
019 |
|
|
|a 1036786998
|
020 |
|
|
|a 9781493974450
|q (electronic bk.)
|
020 |
|
|
|a 1493974459
|q (electronic bk.)
|
020 |
|
|
|z 9781493974436
|q (print)
|
020 |
|
|
|z 1493974432
|
024 |
7 |
|
|a 10.1007/978-1-4939-7445-0
|2 doi
|
029 |
1 |
|
|a UKMGB
|b 019127359
|
035 |
|
|
|a (OCoLC)1034691253
|z (OCoLC)1036786998
|
050 |
|
4 |
|a RC270
|
049 |
|
|
|a GWRE
|
245 |
0 |
0 |
|a Integrin targeting systems for tumor diagnosis and therapy /
|c edited by Eleonora Patsenker.
|
264 |
|
1 |
|a New York, NY :
|b Humana Press,
|c 2018.
|
300 |
|
|
|a 1 online resource (xi, 226 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in pharmacology and toxicology,
|x 1557-2153
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed May 7, 2018).
|
650 |
|
0 |
|a Tumors
|x Molecular diagnosis
|v Laboratory manuals.
|
650 |
|
0 |
|a Integrins
|v Laboratory manuals.
|
650 |
|
7 |
|a Integrins
|2 fast
|
655 |
|
7 |
|a Laboratory manuals
|2 fast
|
700 |
1 |
|
|a Patsenker, Eleonora,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Integrin targeting systems for tumor diagnosis and therapy.
|d New York, NY : Humana Press, 2018
|z 1493974432
|z 9781493974436
|w (OCoLC)996424019
|
830 |
|
0 |
|a Methods in pharmacology and toxicology,
|x 1557-2153
|
856 |
4 |
0 |
|u https://colorado.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-1-4939-7445-0
|z Full Text (via Springer)
|
880 |
0 |
|
|6 505-00/(S
|a 1. Tumor Targeting by RGD-Grafted PLGA-Based Nanotheranostics Loaded with Paclitaxel and Superparamagnetic Iron Oxides Fabienne Danhier, Pierre Danhier, Nathalie Schleich, Chrystelle Po, S. Laurentc, P. Sibret, C. Jérôme, V. Poucelle, Bernard Gallez, and Véronique Préat 2. Fabrication of cRGD Conjugated Dual Responsive Micelles to Target αvβ5 Integrin Overexpressed Cancer Huacheng He, Remant Bahadur K.C., and Peisheng Xu 3. Copper-Free Click Chemistry Modification of Nanovectors for Integrin Targeted Cancer Therapy Chang-Fang Wang and Hélder A. Santos 4. Preparation, Characterization, and In Vitro and In Vivo Evaluation of PEGylated Liposomal Doxorubicin Modified with Different cRGD Peptides Mohamadreza Amin and Mahmoud Reza Jaafari 5. Preparation of Heterobivalent and Multivalent Radiopharmarmaceuticals to Target Tumors Over-Expressing Integrins Guillermina Ferro-Flores, Blanca Ocampo-García, Clara Santos-Cuevas, Nallely Jiménez-Mancilla, Myrna Luna-Gutiérrez, Flor de M. Ramírez, Enrique Morales-Avila, Luis M. De León-Rodríguez, and Erika Azorín-Vega 6. 177Lu Labeled RGD-BBN Peptide for Targeting Prostate Cancer Lei Jiang and Zhen Cheng 7. Integrin-Mediated Targeting of Liposomally-Bound siRNAs to Tumor Vasculatures Poulami Majumder and Arabinda Chaudhuri 8. Integrin αvβ3-Targeted Optical Imaging with Metal Oxide Nanomaterials: Focusing on Zinc Oxide Hao Hong and Weibo Cai 9. Integrin Targeting Using RGD-Based Peptide Amphiphiles Poonam Saraf, Xiaoling Li, and Bhaskara Jasti 10. Cyclic-RGDfK-Directed Docetaxel Loaded Nanomicelles for Angiogenic Tumor Targeting Hitesh Kulhari, Deep Pooja, Shweta Shrivastava, T. Srinivasa Reddy, Ayan Kumar Barui, Chitta Ranjan Patra, Naidu V.G.M., David J. Adams, and Ramakrishna Sistla 11. Targeting Glioma Cancer Cells with Fluorescent Nanodiamonds Via Integrin Receptors Jitka Neburkova, Miroslav Hajek, Ivan Rehor, Jiri Schimer, Frantisek Sedlak, Jan Stursa, Martin Hruby, and Petr Cigler 12. NIR Imaging-Guided Photothermal Therapy by cRGD-Conjugated Solid Lipid Nanoparticles Encapsulating IR-780 Ye Kuang, Kunchi Zhang, Min Liu, and Renjun Pei 13. Synergistic Active Targeting to B16F10 Tumors by αvβ3/CD44-Targeted Nanoparticles Loaded with Docetaxel Sanjun Shi.
|
915 |
|
|
|a -
|
956 |
|
|
|a Springer Protocols
|
956 |
|
|
|b Springer Nature - Complete Protocols
|
998 |
|
|
|b Added to collection springerlink.protocols
|
994 |
|
|
|a 92
|b COD
|
999 |
f |
f |
|s 00d1de4e-0351-4135-a6cf-a90ede5ac262
|i faf18587-5a5c-4e1a-8faa-e0cc3139dac3
|
952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Online
|c Online
|d Online
|e RC270
|h Library of Congress classification
|i web
|